Xilio Therapeutics(XLO) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2026 Xilio Therapeutics, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-40925 85-1623397 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 828 Winter Street, Suite 300 Waltham, Massachusetts 02451 (Address ...